Medical devices, pharmaceutical products, and biological research materials share a common requirement that is easy to state but difficult to achieve: they must be free from contamination. In these industries, the materials used to manufacture, transport, and contain process fluids are not passive bystanders. They are active participants in product quality. If a fluid-wetted surface introduces even trace levels of particulate, ionic, or organic contamination, the consequences can range from compromised test results to regulatory failure to direct harm to patients.
This is why high purity standards are not just a box to check. They are foundational to safe, effective, and compliant operations across the medical and life sciences landscape.
The Real Cost of Contamination
In pharmaceutical manufacturing, drug products come into contact with numerous material surfaces throughout production, storage, and delivery. Tubing, fittings, manifolds, tanks, and connectors all present potential contamination pathways. The two categories of concern that drive material selection decisions in this space are extractables and leachables.
Extractables are chemical compounds that can be released from a material under exaggerated laboratory conditions such as elevated temperature or aggressive solvents. Leachables are the subset of those compounds that actually migrate into the drug product under normal conditions of use. When leachables enter a process stream, they can alter drug stability, reduce shelf life, degrade the efficacy of active pharmaceutical ingredients, or introduce toxic compounds that pose direct risks to patient safety.
Regulatory bodies including the FDA require manufacturers to identify, measure, and control these compounds. The United States Pharmacopeia has published dedicated chapters, including USP <665> and USP <1665>, that provide frameworks for assessing the chemical suitability of plastic components used in pharmaceutical and biopharmaceutical manufacturing. The message from regulators is clear: if a material cannot demonstrate that it will not compromise the product it touches, it does not belong in the process.
Why Material Selection Is a Purity Decision
Not all plastics are created equal when it comes to purity. Many conventional polymers contain additives such as plasticizers, stabilizers, colorants, and processing aids. Under process conditions involving heat, pressure, or chemical exposure, these additives can migrate out of the material and into the fluid stream. In medical and life sciences applications, this is unacceptable.
Fluoroplastics occupy a unique position in this conversation. Materials like PFA, PTFE, and FEP are chemically inert, meaning they do not react with or absorb the vast majority of process chemicals. They contain no plasticizers or other foreign additives in their base formulations. Their surfaces are naturally non-wetting and non-leaching, which means process fluids pass through without picking up contaminants from the material itself. These properties make fluoroplastics the preferred choice for fluid-wetted components in environments where purity cannot be compromised.
PFA in particular has become the standard for ultra-high-purity applications because it combines this chemical inertness with melt processability. It can be extruded into custom tubing, molded into complex shapes, and fusion welded into seamless assemblies that eliminate potential leak paths and dead legs where contaminants could accumulate.
Where High Purity Standards Apply
The need for contamination-free fluid handling spans several interconnected sectors within the medical and life sciences space.
Pharmaceutical Manufacturing
Drug production involves aggressive chemicals, purified water systems, and active pharmaceutical ingredients that are sensitive to even trace contamination. Fluoroplastic tubing, fittings, and pipe manifolds are used throughout chemical delivery, process filtration, and fluid transfer to ensure that the product remains unaltered from formulation through final fill.
Biomedical Device Manufacturing
Components used in or alongside medical devices must meet strict biocompatibility and cleanliness standards. Fluoroplastic parts that come into contact with biological fluids, diagnostic reagents, or sterilization media must be fabricated and packaged under controlled conditions to prevent introducing particulate or chemical contamination. This is where clean room preparation and packaging becomes a critical part of the manufacturing process rather than an afterthought.
Life Sciences and Genome Research
In life sciences and genome research, the fluids being handled are often biological samples, reagents, or culture media where even parts-per-billion levels of contamination can compromise experimental integrity. High purity fluoroplastic assemblies provide the inert, non-leaching fluid pathways these applications require.
The Manufacturing Environment Matters as Much as the Material
Selecting the right fluoroplastic is only part of the equation. How that material is fabricated, machined, and handled before it reaches the end user is equally important. A PFA fitting manufactured on equipment that also machines metals risks introducing metallic particulate contamination that defeats the purpose of choosing a high purity material in the first place.
This is why dedicated plastics-only manufacturing environments exist. When the fabrication facility processes nothing but high-performance plastics, the risk of cross-contamination from metals, lubricants, or other foreign materials is eliminated at the source. Combine that with 100% quality control inspection on every part, pressure testing on all applicable components, and clean room preparation and packaging, and the result is a component that meets the purity standards these industries demand.
Laser etching also plays a role in traceability and compliance. Permanently marking part numbers, material identifiers, chemical compatibility details, and directional indicators directly onto fluoroplastic surfaces supports the documentation and traceability requirements that regulated industries rely on.
How Crist Group Serves Medical and Life Sciences Applications
At Crist Group, we fabricate high purity fluoroplastic components for the biomedical, life sciences, and genome research industries. Our 25,000-square-foot facility in Woodland, California is dedicated exclusively to plastics-only manufacturing with zero metal machining, which eliminates cross-contamination risk at the facility level.
We work with PFA, FEP, PTFE, PTFM (weldable PTFE), ECTFE, and PVDF, and we handle everything from design and engineering through prototyping and production in-house. Every part undergoes 100% quality control inspection, and all applicable components are pressure tested before shipment.
If your application demands high purity fluoroplastic components that meet the standards of medical and life sciences manufacturing, contact Crist Group to discuss your project requirements.
